Latest News

Might the tariff risk for pharmaceutical stocks be less than you think?

With the stock market sliding and fear running high, Suze Orman jumped in this week with a reminder that's equal parts firm and ...

Investor risk appetite continues to look shaky in the face of the ongoing drama around trade wars.

Bessent’s remarks come after China hiked tariffs on goods imported from the U.S. to 84% from 34% earlier. The Xi Jinping administration noted that the new tariffs would take effect on Thursday.

The global selloff deepened after President Trump hiked US trade tariffs, as planned, to a 100-year high, jolting investors and further straining fragile sentiment.

Even bigger budget deficits are now in store due to the first $1 trillion defense budget.

Procter & Gamble (PG) shares are at support. They are also oversold. There is a good chance they rally off of this level.

Sirius XM has a stable business model that is based on recurring subscription revenues, according to one analyst.

And we take a look at Texas Instruments and Taiwan Semiconductor.

NDX futures have declined to a morning low at 16607.30.

Affirm and Shopify accelerate global expansion of Shop Pay Installments, starting with Canada and UK this summer, with plans for Australia and Western Europe.

The US market session of Wednesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.

Bitcoin's (CRYPTO: BTC) sharp decline has sparked renewed debate: is Bitcoin truly a risk asset, or is it evolving into a safe haven?

Pfizer Inc (NYSE:PFE) shares are moving lower Wednesday alongside several pharmaceutical giants after President Donald Trump indicated that tariffs on pharmaceutical companies are on the horizon.

A fundamental analysis of (NYSE:OSK): Reasonable Growth, Debt Levels, and a High ROIC Make OSHKOSH CORP (NYSE:OSK) Appealing to Quality Investors.

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.